The table below shows Aptevo Therapeutics Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
$3.11M
$12.29M
$4.31M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$14.54M
$14.38M
$17.11M
$17.88M
$18.99M
$17.85M
SG&A
$11.77M
APVO annual revenue (10-K history)
Aptevo Therapeutics Inc. reported annual revenue of $3.11M for fiscal year 2022. That is down 74.7% from $12.29M in fiscal 2021. Over the 8 fiscal years shown, annual revenue declined from $33.60M (FY 2015) to $3.11M. Figures come from the company's audited annual reports as filed with the SEC.